In re Guardianship of Tschumy
No. A12-2179 (Minn. Sept. 17, 2014)
Kazmi v. Dep’t of Fin. and Prof’l Regulation
No. 1-13-0959 (Ill. App. Ct. Sept. 10, 2014)
Miss. State Bd. of Med. Licensure v. Harron
No. 2013-SA-00654-COA (Miss. Ct. App. Sept. 16, 2014)
U.S. ex rel. Tahlor v. AHS Hosp. Corp.
Civ. No. 2:08-cv-02042 (WJM) (D. N.J. Sept. 10, 2014)
YOUR GOVERNMENT AT WORK
OIG Issues Special Advisory Bulletin
The Office of Inspector General (“OIG”) issued a Special Advisory Bulletin warning pharmaceutical manufacturers that the practice of offering copayment coupons to induce the purchase of drugs could violate the anti-kickback statute. The Bulletin was released concurrently with an Office of Evaluation and Inspections report analyzing the safeguards that pharmaceutical manufacturers can use to prevent their coupon programs from inducing the purchase of drugs paid for under Medicare Part D.
OIG Issues Advisory Opinion
Advisory Opinion No. 14-08 involved the proposed use of a “preferred hospital” network as part of Medicare Supplemental Health Insurance (“Medigap”) policies. A Medigap plan asked the OIG whether the plan could indirectly contract with hospitals for discounts on the otherwise applicable Medicare inpatient deductibles for its policyholders and also provide a premium credit at the time of policy renewal for policyholders who use a network hospital for an inpatient stay. The OIG concluded that the proposed arrangement would not be subject to civil monetary penalties or administrative sanctions.